Prevention of activation of coagulation during haemodialysis and the use of warfarin.
Sagedal
Solbjørg
S
D000925:Anticoagulants / Q000494:pharmacology*; D001777:Blood Coagulation / Q000187:drug effects*; D017984:Enoxaparin / Q000494:pharmacology*; D006493:Heparin / Q000494:pharmacology*; D006801:Humans; D010446:Peptide Fragments / Q000097:blood; D011498:Protein Precursors / Q000097:blood; D011516:Prothrombin; D006435:Renal Dialysis; D014859:Warfarin / Q000494:pharmacology*
D000925:Anticoagulants; D017984:Enoxaparin; D010446:Peptide Fragments; D011498:Protein Precursors; D014859:Warfarin; C029733:prothrombin fragment 1; C044183:prothrombin fragment 2; D011516:Prothrombin; D006493:Heparin